Hope Is a Bad Reason to Change Gears<br />By Rev Shark<br />RealMoney.com Contributor<br />8/27/2009 8:52 AM EDT <br /><br />Hope is the only universal liar who never loses his reputation for veracity. <br />-- Robert G. Ingersoll<br /><br />Although we have had three days of very sedate action and things look very quiet again this morning, there is no shortage of talk about whether or not the market is ready to top out. It shouldn't be too surprising that so many are focused on the death of this rally -- it has been one of the most difficult and disliked moves I have ever experienced. It's not only the bears who have been frustrated with this market that has gone up in a straight line for months -- bulls who could never position themselves properly or who exited too early are feeling the pain, too. <br /><br />In retrospect, it shouldn't be at all surprising that a rally of this magnitude and intensity would leave so many confounded after the massive breakdown that we had experienced. If you weren't gun-shy about buying after what happened in the market from last summer to this past March, then you must have been living on another planet. <br /><br />In addition to fresh memories about a market that destroyed a huge percentage of many portfolios, many investors still have serious doubts about the economic recovery. The experience of many with housing, jobs and the pace of the recovery in general is just not consistent with what they see the market doing. They can't help but doubt the market's optimism when the anecdotal evidence is so different. <br /><br />The result has been one of the most unloved rallies that we have ever seen, but the fact that the uptrend has been so unloved is what has kept it going for so long with so few pullbacks. Folks don't want to embrace it, but they feel they have no choice and are tired of underperforming. They keep looking for chances to buy and have done so on every minor dip. The result has been a market that just doesn't pull back. <br /><br />We have now had three days of flat action and we're seeing more and more calls for some sort of market consolidation at a minimum. When this has happened in recent months, the market confounded the bears and put in another leg up. <br /><br />Are we really at a point where this very hated rally is about to pause? There are a slew of good fundamental arguments and even seasonal factors that favor the bears, but there is one big problem -- the market is still showing few if any signs of falling apart. Yes, we are extended and there is some signs of slowing momentum, but that has been the case numerous times in the last six months, and the bulls came roaring back each time. <br /><br />I'd like to see some downside myself because I think it would lead to some better trading, but it just isn't happening yet. The biggest danger for market players is letting their hopes guide their investing. Until the character of the market actually changes, we have to stick with it no matter how much we may hope that we might pull back. <br /><br />It is quiet out there this morning and not much is happening, and that makes it even more dangerous for folks who are hoping too hard for the market trend to be change. Don't let your hopes blind you to what is actually in front of you -- a market that still has not done much of anything wrong. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: JAS +9.2%, LONG +6.7%, CISG +4.5% (light volume), VIP +3.4%, GES +3.0%, FRED +1.6%, TD +1.5% (light volume)... Select financial related names showing strength: AIB +8.8%, AIG +8.8% (continued momentum with Forbes reporting AIG likely to rise sharply when trading resumes Thursday after co's chief said he was looking to its founder, Greenberg, for help in rescuing the co), PMI +3.5%, C +2.8% (Paulson buying Citi shares - NY Post), RY +2.3%, FNM +2.2%, UBS +2.1%, ING +1.7%... Other news: IMMU +83.1% (light volume, UCB and Immunomedics announce positive results for epratuzumab Ph. IIb study in systemic lupus erythematosus), ATSI +10.3% (announces FDA approval for a landmark clinical investigation of the ATS 3f Aortic Bioprosthesis), GERN +6.5% (comments on FDA hold on spinal cord injury trial), CLNE +5.5% (announces its customers and government agency partners awarded $34 million in DOE stimulus grants), WPRT +4.1% (continued momentum from yesterday's late surge higher), NOK +3.6% (still checking), CHU +3.4% (Apple must still complete negotiations with China Unicom, which is expected to carry the iPhone - WSJ), BEAT +3.0% (continued strength from yesterday's 25% jump), BA +2.4% (announces New 787 schedule; first flight of the 787 Dreamliner is expected by the end of 2009 and first delivery is expected to occur in 4Q10), NOC +2.2% (awarded $2.4 bln contract for USS Theodore Roosevelt refueling and complex overhaul and Department of Defense awards co $3.44 bln modified (ceiling increase) contract), BIG +1.4% and UPL +1.2% (Cramer makes positive comments on MadMoney)... Analyst comments: DLTR +2.1% (upgraded to Overweight at Barclays), F +1.2% (Hearing upgraded to Strong Buy at boutique firm), ANR +1.0% (reinstated with Overweight at Barclays).<br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: CONN -10.8% (light volume), APWR -10.6%, SIGM -9.5% (also downgraded to Hold at Collins Stewart), ENER -5.0%, AEO -4.7%, DEO -4.0%, CWTR -2.9%, TOL -1.9%... Select solar related names ticking lower following ENER results: LDK -2.3%, CSIQ -1.4%, FSLR -1.3%, SPWRA -1.0%... Other news: ALKS -10.9% (discloses notification that Ortho-McNeil-Janssen Pharmaceuticals decided not to pursue further development of the four-week long-acting injectable formulation of risperidone; also downgraded to Hold at Jefferies), HGSI -5.2% (continuing to pull back from yesterday's afternoon weakness), CEL -4.4% (trading ex dividend), VG -4.1% (Apple says VG app delayed by technical issues-Barron's Blog; also Bloomberg.com article discusses rally in VG shares and says VG spokesman said solution for technical issue should be simple), ETP -2.2% (discloses it entered into an Equity Distribution Agreement), GNW -1.3% (files mixed securities shelf offering), PHM -1.0% (down in sympathy with TOL)... Analyst comments: MPW -2.4% (downgraded to Underperform at Wells Fargo).